ATE193037T1 - Hochkonzentrierte homogenisierte kollagenzusammensetzungen - Google Patents

Hochkonzentrierte homogenisierte kollagenzusammensetzungen

Info

Publication number
ATE193037T1
ATE193037T1 AT93905918T AT93905918T ATE193037T1 AT E193037 T1 ATE193037 T1 AT E193037T1 AT 93905918 T AT93905918 T AT 93905918T AT 93905918 T AT93905918 T AT 93905918T AT E193037 T1 ATE193037 T1 AT E193037T1
Authority
AT
Austria
Prior art keywords
highly concentrated
collagen compositions
injectability
cross
starting materials
Prior art date
Application number
AT93905918T
Other languages
English (en)
Inventor
George Chu
Brenda Trobaugh
Prema Roa
Original Assignee
Collagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collagen Corp filed Critical Collagen Corp
Application granted granted Critical
Publication of ATE193037T1 publication Critical patent/ATE193037T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Cosmetics (AREA)
AT93905918T 1992-02-28 1993-02-16 Hochkonzentrierte homogenisierte kollagenzusammensetzungen ATE193037T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84377092A 1992-02-28 1992-02-28
PCT/US1993/001289 WO1993017075A1 (en) 1992-02-28 1993-02-16 High concentration homogenized collagen compositions

Publications (1)

Publication Number Publication Date
ATE193037T1 true ATE193037T1 (de) 2000-06-15

Family

ID=25290969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905918T ATE193037T1 (de) 1992-02-28 1993-02-16 Hochkonzentrierte homogenisierte kollagenzusammensetzungen

Country Status (12)

Country Link
US (1) US5428024A (de)
EP (1) EP0632820B1 (de)
JP (1) JP3267972B2 (de)
AT (1) ATE193037T1 (de)
AU (1) AU3665693A (de)
CA (1) CA2128504C (de)
DE (1) DE69328677T2 (de)
DK (1) DK0632820T3 (de)
ES (1) ES2152248T3 (de)
GR (1) GR3034187T3 (de)
PT (1) PT632820E (de)
WO (1) WO1993017075A1 (de)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1014695A (en) * 1994-02-17 1995-08-24 Collagen Corporation Collagen-synthetic polymer conjugates having controlled fiber size distributions
EP0713707A1 (de) * 1994-11-23 1996-05-29 Collagen Corporation Injizierbare, in Situ vernetzbare Kollagenszusammensetzung für die Weichgewebevermehrung
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US6706690B2 (en) * 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6264987B1 (en) 2000-05-19 2001-07-24 Alkermes Controlled Therapeutics Inc. Ii Method for preparing microparticles having a selected polymer molecular weight
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
US6471995B1 (en) 2000-09-27 2002-10-29 Alkermes Controlled Therapeutics, Inc. Ii Apparatus and method for preparing microparticles using liquid-liquid extraction
US20020114843A1 (en) * 2000-12-27 2002-08-22 Ramstack J. Michael Preparation of microparticles having improved flowability
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US7105182B2 (en) * 2001-07-25 2006-09-12 Szymaitis Dennis W Periodontal regeneration composition and method of using same
US20040028676A1 (en) * 2002-08-06 2004-02-12 Klein Dean A. Swallowing system tissue modifier
CN1310946C (zh) * 2002-12-18 2007-04-18 和康生物科技股份有限公司 注射性胶原蛋白的制备方法及其产品
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
CN1968700A (zh) * 2004-04-15 2007-05-23 阿尔克姆斯有限公司 聚合物基的持续释放装置
JP4694163B2 (ja) * 2004-07-26 2011-06-08 株式会社ジーシー 生体吸収性顆粒状多孔質骨補填材の製造方法
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
ATE503465T1 (de) * 2004-10-25 2011-04-15 Celonova Biosciences Germany Gmbh Beladbare polyphosphazenhaltige teilchen für therapeutische und/oder diagnostische anwendungen sowie herstellungs- und verwendungsverfahren dafür
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US20060100138A1 (en) * 2004-11-10 2006-05-11 Olsen David R Implantable collagen compositions
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
KR20090017654A (ko) * 2006-05-31 2009-02-18 백스터 인터내셔널 인코포레이티드 척수 수술에서 세포 내성장을 통제하고 조직 재생을 조절하는 방법
TWI436793B (zh) 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
WO2008118712A1 (en) * 2007-03-22 2008-10-02 Alkermes, Inc. Coacervation process
EP2157967B1 (de) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspensionsformulierungen insulinotroper peptide und ihre verwendung
CA2687990A1 (en) * 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US20080317865A1 (en) * 2007-06-20 2008-12-25 Alkermes, Inc. Quench liquids and washing systems for production of microparticles
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
PT2818184T (pt) 2007-11-16 2019-01-28 Aclaris Therapeutics Inc Composições e métodos para o tratamento de púrpura
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8167787B2 (en) 2008-01-03 2012-05-01 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
US8707960B2 (en) * 2008-05-12 2014-04-29 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US9439801B2 (en) 2012-06-29 2016-09-13 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US20120089491A1 (en) * 2008-07-02 2012-04-12 Katia Weber System and method of providing enhanced transaction data
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
CA2735173C (en) 2008-09-02 2017-01-10 Tautona Group Lp Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US9039783B2 (en) * 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
US9162006B2 (en) * 2009-06-16 2015-10-20 Baxter International Inc. Hemostatic sponge
EP3323423B1 (de) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
WO2011079336A1 (en) * 2009-12-16 2011-07-07 Baxter International Inc. Hemostatic sponge
US20110172180A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US8586562B2 (en) 2010-03-12 2013-11-19 Allergan Industrie, Sas Fluid compositions for improving skin conditions
EP2547297A4 (de) * 2010-03-19 2014-08-06 Revent Medical Inc Systeme und verfahren zur behandlung von schlafapnoe
CA2793213A1 (en) 2010-03-19 2011-09-22 Revent Medical Inc. Systems and methods for treatment of sleep apnea
EP4062950A1 (de) 2010-03-22 2022-09-28 Allergan, Inc. Spritze mit dermalem füllstoff zur verstärkung von weichgewebe
US9987114B2 (en) 2010-03-24 2018-06-05 Covidien Lp Combination three-dimensional surgical implant
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
AU2011255195A1 (en) 2010-05-21 2012-11-29 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
MX344402B (es) 2010-06-01 2016-12-14 Baxter Int Inc * Proceso para elaborar composiciones hemostaticas secas y estables.
AU2011260260B2 (en) 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
ES2682302T3 (es) 2010-06-01 2018-09-19 Baxter International Inc Proceso para la producción de composiciones hemostáticas secas y estables
JP2013538075A (ja) 2010-07-26 2013-10-10 レベント メディカル インコーポレイテッド 睡眠時無呼吸を治療するためのシステム及び方法
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9447169B2 (en) 2011-03-04 2016-09-20 Orthovita, Inc. Flowable collagen-based hemostat and methods of use
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
RU2624239C2 (ru) 2011-06-03 2017-07-03 Аллерган, Инк. Составы кожного наполнителя, включая антиоксиданты
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
ES2938568T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
HK1201212A1 (en) 2011-10-11 2015-08-28 Baxter International Inc Hemostatic compositions
SG11201401878SA (en) 2011-10-27 2014-09-26 Baxter Int Hemostatic compositions
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US20230270916A1 (en) * 2012-03-14 2023-08-31 MAM Holdings of West Florida, L.L.C. Collagen compositions and uses for biomaterial implants
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
DE102012213496A1 (de) 2012-07-31 2014-05-15 Amedrix Gmbh Kit, dessen Verwendung und Verfahren zum Auffüllen von Bindegewebe der Haut
CA2901753C (en) 2013-03-04 2023-08-22 DERMELLE, LLC d/b/a ETERNOGEN, LLC Injectable in situ polymerizable collagen composition
EP3010419B1 (de) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vakuumerweiterte trockenzusammensetzung und spritze zum zurückhalten davon
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
RU2715234C2 (ru) 2015-02-13 2020-02-26 Аллерган Эндюстри, Сас Имплантаты для моделирования, увеличения или коррекции частей лица, например подбородка
FR3033697B1 (fr) * 2015-03-17 2020-03-27 Universite Pierre Et Marie Curie (Paris 6) Suspensions de collagene injectables, leur procede de preparation et leurs utilisations, notamment pour la formation de matrices denses de collagene
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
AU2018230378A1 (en) 2017-03-09 2019-10-31 Baxter Healthcare Sa Solvent deposition system and methods
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
EP4395796A4 (de) 2021-09-01 2024-12-25 Shanghai Qisheng Biological Preparation Co., Ltd. Knorpelregeneration mit injizierbaren, in situ polymerisierbaren collagenzusammensetzungen mit chondrozyten oder stammzellen
EP4457266A4 (de) 2021-12-28 2025-10-22 Shanghai Qisheng Biological Preparation Co Ltd Hyaluronsäure-kollagen-copolymer-zusammensetzungen und medizinische anwendungen davon
CN115429873B (zh) * 2022-08-03 2025-04-15 浙江珂瑞康生物医疗科技有限公司 一种天然未变性注射用胶原溶液及其制备方法
CN119656385B (zh) * 2024-12-16 2025-07-25 北京京宇一美生物科技有限责任公司 一种注射用复配胶原蛋白填充剂的制备方法
CN121015973A (zh) * 2025-08-26 2025-11-28 河北柯瑞生物医药有限公司 一种胶原蛋白植入剂及其制备方法
CN121623000B (zh) * 2026-01-30 2026-05-05 北京博辉瑞进生物科技股份有限公司 辐照交联胶原注射填充剂及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US4424208A (en) * 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
US4582640A (en) * 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
FR2530955B1 (fr) * 1982-07-30 1987-11-13 Hecmati Michel Implant anti-ride et son procede de fabrication
US4642117A (en) * 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
GB8708009D0 (en) * 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials

Also Published As

Publication number Publication date
CA2128504C (en) 2009-02-03
GR3034187T3 (en) 2000-11-30
WO1993017075A1 (en) 1993-09-02
US5428024A (en) 1995-06-27
JPH07504450A (ja) 1995-05-18
CA2128504A1 (en) 1993-09-02
DE69328677T2 (de) 2000-08-31
EP0632820A1 (de) 1995-01-11
DE69328677D1 (de) 2000-06-21
DK0632820T3 (da) 2000-10-02
ES2152248T3 (es) 2001-02-01
PT632820E (pt) 2000-11-30
EP0632820B1 (de) 2000-05-17
AU3665693A (en) 1993-09-13
JP3267972B2 (ja) 2002-03-25
EP0632820A4 (de) 1995-06-07

Similar Documents

Publication Publication Date Title
DE69328677D1 (de) Hochkonzentrierte homogenisierte kollagenzusammensetzungen
PT959873E (pt) Composicao de gel e metodos
EP0730465A4 (de) Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
CA2434964A1 (en) Carrier with solid fibrinogen and solid thrombin
ES2300276T3 (es) P40 de interleuquina-12 de mamifero e interleuquina b30. sus combinaciones. anticuerpos. usos en composiciones farmaceuticas.
ZA947337B (en) Use of angiotensin II analogs in tissue repair
FI964600A0 (fi) Kopolymeeri-1 parannuksia kopolymeerien koostumuksiin
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
AU697005B2 (en) Implantable molded articles for the administration of active substances to plants
CA2010909A1 (en) Storage-stable whitener formulation
BR9809483A (pt) Composição de reticulação, processo para faze-la, e, uso da mesma.
CA2241464A1 (en) Nisin in combination with glycerol monolaurate active against helicobacter
AU2670195A (en) Use of gel formulations as dressing compositions
ATE282635T1 (de) Glp-1 analoge
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
NO953995D0 (no) Ionenolymere som anthelmintica i dyr
FI972054A0 (fi) Immunogeenisiä koostumuksia
CA2062779A1 (en) Sterilizing gas composition comprising monochlorotetrafluorethane and ethylene oxide
ATE172107T1 (de) Sonnenschutzzubereitung mit erhöhtem lichtschutzfaktor
GB8334035D0 (en) Antithrombotic &/antihypertensive compositions
CO4230178A1 (es) Acidos y esteres naftalen-dicarboxilicos substituidos con grupos aroilos.
DE69419179D1 (de) Polymerzusammensetzungen
CA2223960A1 (en) Reconstituted collagen fiber segment compositions and methods of preparation thereof
CO4870783A1 (es) Composicion de poliester
IT1254333B (it) Composizioni polimeriche comprendenti poliesteri alifatici ed elastomeri epicloridrinici caratterizzate da elevata resistenza alla degradazione termica.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification